<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Commenti a: Farmaceutica, Uda (Egualia): &#8220;Cina e Usa grandi big ma in Italia manifattura di rilievo&#8221; &#8216;Per restare competitivi medicinali equivalenti e biosimilari siano sostenibili sotto il profilo economico e industriale&#8217;	</title>
	<atom:link href="https://www.lafrecciaweb.it/2026/11/09/farmaceutica-uda-egualia-cina-e-usa-grandi-big-ma-in-italia-manifattura-di-rilievo-per-restare-competitivi-medicinali-equivalenti-e-biosimilari-siano-sostenibili-sotto-il-profilo-economico-e/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.lafrecciaweb.it/2026/11/09/farmaceutica-uda-egualia-cina-e-usa-grandi-big-ma-in-italia-manifattura-di-rilievo-per-restare-competitivi-medicinali-equivalenti-e-biosimilari-siano-sostenibili-sotto-il-profilo-economico-e/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=farmaceutica-uda-egualia-cina-e-usa-grandi-big-ma-in-italia-manifattura-di-rilievo-per-restare-competitivi-medicinali-equivalenti-e-biosimilari-siano-sostenibili-sotto-il-profilo-economico-e</link>
	<description>la velocità dell&#039;informazione</description>
	<lastBuildDate>Mon, 09 Nov 2026 18:55:00 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.11</generator>
</channel>
</rss>
